You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TRK

Showing 1 - 25 of 96
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Chuo Ku (TRK-950, Ramucirumab,

Not yet recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • TRK-950
  • +2 more
  • Chuo Ku, Japan
    Osaka International Cancer Institute
Sep 14, 2023

Solid Tumor Trial in Chuo Ku (TRK-950)

Recruiting
  • Solid Tumor
  • TRK-950
  • Chuo Ku, Tokyo, Japan
    National Cancer Center Hospital
Jul 6, 2022

Topcon Pachymeter TRK-3 to Evaluate Agreement and Precision

Completed
  • Corneal Thickness
  • SP-1P
  • Tokyo, Japan
    Samoncho Clinic
Jul 19, 2022

Chemo-induced Peripheral Neuropathy Trial (TRK-750/Placebo, Placebo/TRK-750)

Withdrawn
  • Chemotherapy-induced Peripheral Neuropathy
  • TRK-750/Placebo
  • Placebo/TRK-750
  • (no location specified)
Feb 27, 2022

Topcon Tonometers CT-800 and TRK-2P and Haag-Streit Goldmann

Completed
  • Intraocular Pressure
  • Topcon CT-800
  • Topcon TRK-2P
  • Andover, Massachusetts
    Andover Eye Associates
Jun 6, 2022

Clinical Study of the Topcon Tonometer TRK-3

Completed
  • Intraocular Pressure
  • tonometer
  • Tokyo, Japan
  • +1 more
Jul 19, 2022

Called VICTORIA to Learn More About How Well Larotrectinib Works

Active, not recruiting
  • Solid Tumors Harboring NTRK Fusion
  • Larotrectinib(Vitrakvi, BAY2757556)
  • Data on other treatments
  • Whippany, New Jersey
    Bayer
Aug 22, 2022

Locally Advanced or Metastatic Solid Carcinomas, Colon Cancer, Cholangiocarcinoma Trial in Phoenix, Scottsdale, Lyon (TRK-950)

Completed
  • Locally Advanced or Metastatic Solid Carcinomas
  • +2 more
  • TRK-950
  • Phoenix, Arizona
  • +2 more
Oct 14, 2021

Solid Tumor, Colorectal Cancer, Cholangiocarcinoma Trial in France, United States (TRK-950, Irinotecan, Leucovorin)

Recruiting
  • Solid Tumor
  • +11 more
  • TRK-950
  • +14 more
  • Scottsdale, Arizona
  • +13 more
Oct 2, 2022

Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial in Houston (Larotrectinib Sulfate)

Recruiting
  • Locally Advanced Malignant Solid Neoplasm
  • Metastatic Malignant Solid Neoplasm
  • Larotrectinib Sulfate
  • Houston, Texas
    M D Anderson Cancer Center
Apr 18, 2022

CNS Tumor, Infantile Fibrosarcoma, Recurrent Acute Leukemia Trial in Canada, United States (Larotrectinib Sulfate)

Active, not recruiting
  • Central Nervous System Neoplasm
  • +4 more
  • Larotrectinib Sulfate
  • Birmingham, Alabama
  • +81 more
Jan 24, 2023

Solid Tumors Harboring NTRK Fusion Trial in Mannheim (Selitrectinib (BAY2731954))

Completed
  • Solid Tumors Harboring NTRK Fusion
  • Selitrectinib (BAY2731954)
  • Mannheim, Baden-Württemberg, Germany
    CRS Clinical-Research-Services Mannheim GmbH
Dec 28, 2020

Solid Tumors Harboring NTRK Fusion Trial in United States (Larotrectinib (Vitrakvi, BAY2757556))

Completed
  • Solid Tumors Harboring NTRK Fusion
  • Larotrectinib (Vitrakvi, BAY2757556)
  • Aurora, Colorado
  • +7 more
May 11, 2021

Solid Tumors Harboring NTRK Fusion Trial in Worldwide (Selitrectinib (BAY2731954))

Active, not recruiting
  • Solid Tumors Harboring NTRK Fusion
  • Selitrectinib (BAY2731954)
  • La Jolla, California
  • +28 more
Aug 18, 2022

Lung Infection, Pneumonia, Ventilator-Associated, Infection, Bacterial Trial in Worldwide (AR-301, Placebo)

Recruiting
  • Lung Infection
  • +3 more
  • Sacramento, California
  • +139 more
Feb 25, 2022

Solid Tumors Harboring NTRK Fusion Trial in Worldwide (Larotrectinib (Vitrakvi, BAY2757556))

Recruiting
  • Solid Tumors Harboring NTRK Fusion
  • Larotrectinib (Vitrakvi, BAY2757556)
  • Los Angeles, California
  • +50 more
Jan 29, 2023

Schizophrenia Trial in Shanghai (Cognitive Remediation Therapy, Clozapine)

Completed
  • Schizophrenia
  • Shanghai, Shanghai, China
    Huangpu District Mental Health Center
Dec 19, 2021

NTRK Family Gene Mutation Trial in Germany

Recruiting
  • NTRK Family Gene Mutation
    • Berlin, Germany
    • +22 more
    Jan 18, 2023

    Locally Advanced Solid Tumors, Metastatic Solid Tumors, Lymphoma Trial in Worldwide (Oral repotrectinib (TPX-0005))

    Recruiting
    • Locally Advanced Solid Tumors
    • +3 more
    • Oral repotrectinib (TPX-0005)
    • Los Angeles, California
    • +27 more
    Aug 9, 2022

    Called EPI VITRAKVI to Compare Treatment Results in Infantile

    Completed
    • Locally Advanced or Metastatic Infantile Fibrosarcoma Harboring an NTRK Gene Fusion
    • Infantile Fibrosarcoma
    • Larotrectinib (Vitrakvi, BAY2757556)
    • Standard of Care
    • Multiple Locations, France
      Multiple Locations
    Jan 10, 2023

    Glioblastoma Multiforme Trial run by the NCI (AZD7451)

    Completed
    • Glioblastoma Multiforme
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 14, 2019

    A Retro-/Prospective, Non-interventional, Cohort Study in Adult

    Active, not recruiting
    • Solid Tumor, Adult
    • +2 more
      • Amiens, France
      • +3 more
      Jul 22, 2022

      Solid Tumor Trial (TL118 Capsule)

      Not yet recruiting
      • Solid Tumor
      • TL118 Capsule
      • (no location specified)
      Aug 18, 2023

      High Grade Glioma, Diffuse Intrinsic Pontine Glioma Trial in Worldwide (Larotrectinib, Larotrectinib surgical)

      Recruiting
      • High Grade Glioma
      • Diffuse Intrinsic Pontine Glioma
      • Aurora, Colorado
      • +17 more
      Aug 10, 2022

      Non-small-cell Lung Cancer With Somatic EGFR Mutations Trial (Afatinib, Pemetrexed)

      Terminated
      • Non-small-cell Lung Cancer With Somatic EGFR Mutations
      • (no location specified)
      Apr 18, 2019